JP2013046616A5 - - Google Patents

Download PDF

Info

Publication number
JP2013046616A5
JP2013046616A5 JP2012202508A JP2012202508A JP2013046616A5 JP 2013046616 A5 JP2013046616 A5 JP 2013046616A5 JP 2012202508 A JP2012202508 A JP 2012202508A JP 2012202508 A JP2012202508 A JP 2012202508A JP 2013046616 A5 JP2013046616 A5 JP 2013046616A5
Authority
JP
Japan
Prior art keywords
base sequence
seq
sequence represented
rna strand
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012202508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013046616A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012202508A priority Critical patent/JP2013046616A/ja
Priority claimed from JP2012202508A external-priority patent/JP2013046616A/ja
Publication of JP2013046616A publication Critical patent/JP2013046616A/ja
Publication of JP2013046616A5 publication Critical patent/JP2013046616A5/ja
Pending legal-status Critical Current

Links

JP2012202508A 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法 Pending JP2013046616A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012202508A JP2013046616A (ja) 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2010158193 2010-07-12
JP2010158193 2010-07-12
JP2010158192 2010-07-12
JP2010158194 2010-07-12
JP2010158192 2010-07-12
JP2010158194 2010-07-12
JP2012202508A JP2013046616A (ja) 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011530188A Division JP5099570B2 (ja) 2010-07-12 2011-06-28 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Publications (2)

Publication Number Publication Date
JP2013046616A JP2013046616A (ja) 2013-03-07
JP2013046616A5 true JP2013046616A5 (enExample) 2014-08-14

Family

ID=45469308

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2011530189A Expired - Fee Related JP5099571B2 (ja) 2010-07-12 2011-06-28 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2011530188A Expired - Fee Related JP5099570B2 (ja) 2010-07-12 2011-06-28 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2012202509A Pending JP2013034479A (ja) 2010-07-12 2012-09-14 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2012202508A Pending JP2013046616A (ja) 2010-07-12 2012-09-14 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2013264240A Expired - Fee Related JP5845493B2 (ja) 2010-07-12 2013-12-20 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2011530189A Expired - Fee Related JP5099571B2 (ja) 2010-07-12 2011-06-28 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2011530188A Expired - Fee Related JP5099570B2 (ja) 2010-07-12 2011-06-28 ｓｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP2012202509A Pending JP2013034479A (ja) 2010-07-12 2012-09-14 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013264240A Expired - Fee Related JP5845493B2 (ja) 2010-07-12 2013-12-20 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Country Status (5)

Country Link
US (2) US9790491B2 (enExample)
EP (2) EP2594643B1 (enExample)
JP (5) JP5099571B2 (enExample)
CN (2) CN103189511B (enExample)
WO (2) WO2012008301A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5099571B2 (ja) 2010-07-12 2012-12-19 国立大学法人鳥取大学 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法
JP6196163B2 (ja) 2011-03-17 2017-09-13 ミネルバ バイオテクノロジーズ コーポレーション 多能性幹細胞を作製する方法
WO2013059373A2 (en) 2011-10-17 2013-04-25 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
US10034902B2 (en) * 2012-02-22 2018-07-31 Exostem Biotec Ltd. MicroRNAs for the generation of astrocytes
CA2879111A1 (en) * 2012-07-13 2014-01-16 Minerva Biotechnologies Corporation Method for inducing cells to less mature state
US10265347B2 (en) 2013-08-29 2019-04-23 Norimasa Miura Biomolecular group related to cell anti-aging
TW201610152A (zh) * 2013-11-22 2016-03-16 國立臺灣大學 微ｒｎａ１４６－ａ及其於診斷、治療及預防小核醣核酸病毒感染之用途及微ｒｎａ１４６－ａ拮抗劑
CN104109670B (zh) * 2014-03-12 2018-01-05 首都医科大学附属北京安定医院 一种双链siRNA分子及其应用
EP3160968B1 (en) 2014-06-27 2018-10-31 Rhizen Pharmaceuticals S.A. Substituted chromene derivatives as selective dual inhibitors of pi3 delta and gamma protein kinases
EP4674985A3 (en) * 2015-04-24 2026-04-01 The Johns Hopkins University Compositions and methods related to characterizing proviral reservoirs
EP3369417A4 (en) * 2015-10-30 2019-05-01 MIURA, Norimasa RNA MOLECULE FOR REPAIRING DNA DAMAGES
KR102011336B1 (ko) * 2015-12-31 2019-08-16 인터올리고 주식회사 약물 전달 및 안정화를 위한 복합체 및 그 제조방법
JP7327801B2 (ja) * 2017-05-02 2023-08-16 株式会社ペジィー・ファーマ 分化細胞の品質改善方法
US20250345461A1 (en) * 2021-12-29 2025-11-13 Livius Pte. Ltd. Method for repairing hair cycle-related genes and method for treating hair cycle-related diseases using mir-520d-5p
JP2023149907A (ja) * 2022-03-31 2023-10-16 株式会社島津製作所 微生物情報の提供方法および微生物検査システム

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452594A4 (en) * 2001-11-15 2007-01-10 Kyowa Hakko Kogyo Kk INDUCTOR FOR DIFFERENTIATING EMBRYOONAL STEM CELLS TO EODODERMAL CELLS, METHOD FOR OBTAINING THEM AND USE THEREOF
US8609831B2 (en) 2002-09-16 2013-12-17 University Of Southern California RNA-mediated gene modulation
CN1768139A (zh) 2003-02-10 2006-05-03 独立行政法人产业技术总合研究所 通过dna干扰调控基因的表达
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
CA2857878A1 (en) 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
JP2008529606A (ja) 2005-02-04 2008-08-07 オーバーン ユニバーシティ 接触薬物送達システム
WO2006112239A1 (ja) 2005-04-15 2006-10-26 National University Corporation Tottori University ｈＴＥＲＴ発現調節遺伝子
ES2564823T3 (es) 2005-05-27 2016-03-29 Ospedale San Raffaele S.R.L. Vector génico que comprende miARN
WO2006137514A1 (ja) * 2005-06-23 2006-12-28 Locomogene, Inc. シノビオリンの発現もしくは機能阻害物質を有効成分とする癌治療剤、および癌治療剤のスクリーニング方法
CN101864392B (zh) 2005-12-13 2016-03-23 国立大学法人京都大学 核重新编程因子
EP2484782B1 (en) * 2006-01-05 2015-11-18 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
DK2666859T3 (en) 2006-04-03 2019-04-08 Roche Innovation Ct Copenhagen As PHARMACEUTICAL COMPOSITION CONTAINING ANTI-miRNA ANTISENSE OLIGONUCLEOTIDES
CA2704043C (en) * 2007-10-29 2018-09-18 Rosetta Genomics Ltd. Targeting micrornas for the treatment of liver cancer
AU2008297024B2 (en) * 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
JP5697988B2 (ja) 2007-12-27 2015-04-08 プロチバ バイオセラピューティクス インコーポレイティッド 干渉ｒｎａを使用したポロ様キナーゼ発現のサイレンシング方法
WO2009091659A2 (en) * 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
CN101333524B (zh) * 2008-06-25 2010-06-02 中山大学 一个小分子非编码RNA基因hsa-miR-101及其抗肿瘤用途
CN101392251B (zh) * 2008-11-03 2015-07-22 清华大学深圳研究生院 能诱导干细胞向成骨细胞分化的微小rna及其应用
JP2010120881A (ja) * 2008-11-19 2010-06-03 Keio Gijuku ヒト癌タンパク質ＭＤＭ２とヒト癌抑制タンパク質ｐ５３との相互作用阻害ペプチド及びその使用
JP5099571B2 (ja) 2010-07-12 2012-12-19 国立大学法人鳥取大学 ｍｉＲＮＡ導入による新規ｈｉＰＳＣ作製法

Similar Documents

Publication Publication Date Title
MX2024001138A (es) Arn guia modificados.
ZA201902226B (en) Aav treatment of huntington's disease
FI3604532T3 (fi) Uusia crispr-entsyymejä ja järjestelmiä
JP2013034479A5 (enExample)
WO2016106406A3 (en) Rna agents for gst-pi gene modulation
MX2016007980A (es) Acido nucleico que induce acido ribonucleico de interferencia modificado para prevenir una falla en alcanzar el objetivo, y uso del mismo.
EP3372685A3 (en) Cell lines for virus production and methods of use
WO2010014857A3 (en) Chromosome therapy
AR100560A1 (es) Inhibición o regulación por disminución de la glucógeno sintasa mediante la creación de codones de terminación prematuros utilizando oligonucléotidos antisentido
MX358744B (es) Composiciones y métodos para la producción y administración de ácido ribonucleico.
IN2014CN03921A (enExample)
NZ630914A (en) Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
ES2623454T3 (es) Reducción del contenido de ácidos grasos saturados en semillas de plantas
MX2015004853A (es) Produccion de acidos ribonucleicos no poliadenilados estables.
WO2010017154A3 (en) Modulation of toll-like receptor 3 expression by antisense oligonucleotides
Yang et al. Small non-coding RNAs-based bone regulation and targeting therapeutic strategies
AR078848A1 (es) Tecnologia terapeutica de arn de interferencia dirigido al oncogen pdx -1 en tumores neuroendocrinos donde se expresa pdx-1
NZ741841A (en) Antisense oligonucleotides for use in treating alzheimer’s disease
MX2019015143A (es) Rna guias modificados, complejos crispr-ribonucleoproteina y metodos de uso.
WO2014153209A8 (en) Antisense oligonucleotides for treatment of cancer stem cells
JP2012085645A5 (enExample)
JP2010270119A5 (enExample)
WO2015020993A3 (en) RNAi COMPOSITIONS AND METHODS FOR TREATMENT OF FRIEDREICH'S ATAXIA
WO2015153880A3 (en) Modulation of hotair and adipogenesis
Aleksandrova et al. Uses of hydrogel embedded with triple helix micro RNA particle in the treatment of the breast tumors